383 related articles for article (PubMed ID: 30138707)
1. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
[TBL] [Abstract][Full Text] [Related]
2. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
4. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
5. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
Wang J; Ayano E; Maitani Y; Kanazawa H
Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
[TBL] [Abstract][Full Text] [Related]
7. Endocytic Transport of Polyplex and Lipoplex siRNA Vectors in HeLa Cells.
Lazebnik M; Keswani RK; Pack DW
Pharm Res; 2016 Dec; 33(12):2999-3011. PubMed ID: 27585903
[TBL] [Abstract][Full Text] [Related]
8. Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs.
Stremersch S; Vandenbroucke RE; Van Wonterghem E; Hendrix A; De Smedt SC; Raemdonck K
J Control Release; 2016 Jun; 232():51-61. PubMed ID: 27072025
[TBL] [Abstract][Full Text] [Related]
9. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
[TBL] [Abstract][Full Text] [Related]
10. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
11. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
[TBL] [Abstract][Full Text] [Related]
12. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
Podesta JE; Kostarelos K
Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563
[TBL] [Abstract][Full Text] [Related]
13. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
14. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
15. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol-dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO living cells.
Cardarelli F; Pozzi D; Bifone A; Marchini C; Caracciolo G
Mol Pharm; 2012 Feb; 9(2):334-40. PubMed ID: 22196199
[TBL] [Abstract][Full Text] [Related]
17. Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.
Dakwar GR; Braeckmans K; Ceelen W; De Smedt SC; Remaut K
Drug Deliv Transl Res; 2017 Apr; 7(2):241-251. PubMed ID: 27631392
[TBL] [Abstract][Full Text] [Related]
18. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
Lee J; Ahn HJ
Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
[TBL] [Abstract][Full Text] [Related]
19. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis.
Qiu X; Li Z; Han X; Zhen L; Luo C; Liu M; Yu K; Ren Y
Theranostics; 2019; 9(9):2618-2636. PubMed ID: 31131057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
